The present invention is directed to curcumin analogs exhibiting anti-tumor and anti-angiogenic properties, pharmaceutical formulations including such compounds and methods of using such compounds.

A invenção atual é dirigida aos analogs do curcumin que exibem propriedades anti-tumor e anti-angiogenic, formulations pharmaceutical including tais compostos e métodos de usar tais compostos.